Summary

The global Cardiopulmonary Resuscitation Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Cardiopulmonary resuscitation (CPR) is an emergency procedure that combines chest compressions often with artificial ventilation in an effort to manually preserve intact brain function until further measures are taken to restore spontaneous blood circulation and breathing in a person who is in cardiac arrest. It is recommended in those who are unresponsive with no breathing or abnormal breathing, for example, agonal respirations.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Cardiopulmonary Resuscitation Device leading manufacturers including Asahi Kasei, Corpuls, CU Medical Systems, GE Healthcare, Nihon Kohden, Stryker, Zoll Medical, Abbott, Michigan Instruments, Phillips, etc., dominate supply; the top five capture approximately % of global revenue, with Asahi Kasei leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Cardiopulmonary Resuscitation Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Asahi Kasei
Corpuls
CU Medical Systems
GE Healthcare
Nihon Kohden
Stryker
Zoll Medical
Abbott
Michigan Instruments
Phillips
Physio Control
Segment by Type
Manual
Automatic
Segment by Application
Hospital
Pre Hospital
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Cardiopulmonary Resuscitation Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Cardiopulmonary Resuscitation Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cardiopulmonary Resuscitation Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Manual
1.2.3 Automatic
1.3 Market Segmentation by Application
1.3.1 Global Cardiopulmonary Resuscitation Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pre Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cardiopulmonary Resuscitation Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Cardiopulmonary Resuscitation Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Cardiopulmonary Resuscitation Device Sales Estimates and Forecasts 2020-2031
2.4 Global Cardiopulmonary Resuscitation Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Cardiopulmonary Resuscitation Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Cardiopulmonary Resuscitation Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Manual Market Size by Manufacturers
3.5.2 Automatic Market Size by Manufacturers
3.6 Global Cardiopulmonary Resuscitation Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cardiopulmonary Resuscitation Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Cardiopulmonary Resuscitation Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cardiopulmonary Resuscitation Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Cardiopulmonary Resuscitation Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Cardiopulmonary Resuscitation Device Sales and Revenue by Type (2020-2031)
6.4 North America Cardiopulmonary Resuscitation Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cardiopulmonary Resuscitation Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Cardiopulmonary Resuscitation Device Sales and Revenue by Type (2020-2031)
7.4 Europe Cardiopulmonary Resuscitation Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cardiopulmonary Resuscitation Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Cardiopulmonary Resuscitation Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Cardiopulmonary Resuscitation Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Cardiopulmonary Resuscitation Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Cardiopulmonary Resuscitation Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Cardiopulmonary Resuscitation Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cardiopulmonary Resuscitation Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Cardiopulmonary Resuscitation Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Cardiopulmonary Resuscitation Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cardiopulmonary Resuscitation Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Asahi Kasei
11.1.1 Asahi Kasei Corporation Information
11.1.2 Asahi Kasei Business Overview
11.1.3 Asahi Kasei Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.1.4 Asahi Kasei Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Asahi Kasei Cardiopulmonary Resuscitation Device Sales by Product in 2024
11.1.6 Asahi Kasei Cardiopulmonary Resuscitation Device Sales by Application in 2024
11.1.7 Asahi Kasei Cardiopulmonary Resuscitation Device Sales by Geographic Area in 2024
11.1.8 Asahi Kasei Cardiopulmonary Resuscitation Device SWOT Analysis
11.1.9 Asahi Kasei Recent Developments
11.2 Corpuls
11.2.1 Corpuls Corporation Information
11.2.2 Corpuls Business Overview
11.2.3 Corpuls Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.2.4 Corpuls Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Corpuls Cardiopulmonary Resuscitation Device Sales by Product in 2024
11.2.6 Corpuls Cardiopulmonary Resuscitation Device Sales by Application in 2024
11.2.7 Corpuls Cardiopulmonary Resuscitation Device Sales by Geographic Area in 2024
11.2.8 Corpuls Cardiopulmonary Resuscitation Device SWOT Analysis
11.2.9 Corpuls Recent Developments
11.3 CU Medical Systems
11.3.1 CU Medical Systems Corporation Information
11.3.2 CU Medical Systems Business Overview
11.3.3 CU Medical Systems Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.3.4 CU Medical Systems Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 CU Medical Systems Cardiopulmonary Resuscitation Device Sales by Product in 2024
11.3.6 CU Medical Systems Cardiopulmonary Resuscitation Device Sales by Application in 2024
11.3.7 CU Medical Systems Cardiopulmonary Resuscitation Device Sales by Geographic Area in 2024
11.3.8 CU Medical Systems Cardiopulmonary Resuscitation Device SWOT Analysis
11.3.9 CU Medical Systems Recent Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Corporation Information
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.4.4 GE Healthcare Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 GE Healthcare Cardiopulmonary Resuscitation Device Sales by Product in 2024
11.4.6 GE Healthcare Cardiopulmonary Resuscitation Device Sales by Application in 2024
11.4.7 GE Healthcare Cardiopulmonary Resuscitation Device Sales by Geographic Area in 2024
11.4.8 GE Healthcare Cardiopulmonary Resuscitation Device SWOT Analysis
11.4.9 GE Healthcare Recent Developments
11.5 Nihon Kohden
11.5.1 Nihon Kohden Corporation Information
11.5.2 Nihon Kohden Business Overview
11.5.3 Nihon Kohden Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.5.4 Nihon Kohden Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Nihon Kohden Cardiopulmonary Resuscitation Device Sales by Product in 2024
11.5.6 Nihon Kohden Cardiopulmonary Resuscitation Device Sales by Application in 2024
11.5.7 Nihon Kohden Cardiopulmonary Resuscitation Device Sales by Geographic Area in 2024
11.5.8 Nihon Kohden Cardiopulmonary Resuscitation Device SWOT Analysis
11.5.9 Nihon Kohden Recent Developments
11.6 Stryker
11.6.1 Stryker Corporation Information
11.6.2 Stryker Business Overview
11.6.3 Stryker Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.6.4 Stryker Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Stryker Recent Developments
11.7 Zoll Medical
11.7.1 Zoll Medical Corporation Information
11.7.2 Zoll Medical Business Overview
11.7.3 Zoll Medical Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.7.4 Zoll Medical Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Zoll Medical Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Business Overview
11.8.3 Abbott Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.8.4 Abbott Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Abbott Recent Developments
11.9 Michigan Instruments
11.9.1 Michigan Instruments Corporation Information
11.9.2 Michigan Instruments Business Overview
11.9.3 Michigan Instruments Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.9.4 Michigan Instruments Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Michigan Instruments Recent Developments
11.10 Phillips
11.10.1 Phillips Corporation Information
11.10.2 Phillips Business Overview
11.10.3 Phillips Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.10.4 Phillips Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Phillips Recent Developments
11.11 Physio Control
11.11.1 Physio Control Corporation Information
11.11.2 Physio Control Business Overview
11.11.3 Physio Control Cardiopulmonary Resuscitation Device Product Models, Descriptions and Specifications
11.11.4 Physio Control Cardiopulmonary Resuscitation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Physio Control Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Cardiopulmonary Resuscitation Device Industry Chain
12.2 Cardiopulmonary Resuscitation Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Cardiopulmonary Resuscitation Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Cardiopulmonary Resuscitation Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cardiopulmonary Resuscitation Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cardiopulmonary Resuscitation Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details